Clinical trial

OVArian Cancer Non-Interventional Study - OVATAR

NCT02122588

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2014-06-30

PhaseN/A

Study timeline

Study start (actual)2014-06-30Date precision: day

Registry last updated2019-05-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Ovarian, Peritoneal, Fallopian Tube Cancer, BRCAm+ in Russiaunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

RUSSCO (Russian Society of Clinical Oncology)collaborator

Mapped research locations

MoscowRussia1 Saint PetersburgRussia1 NovosibirskRussia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02122588 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.